Global speaker programs
For patients to benefit from new medical innovations, HCPs need to access and understand the latest available data and clinical use of the product.
Feedback from HCPs shows that they prefer to learn about new data and clinical experience through peer-to-peer programs with global expert practitioners who have direct experience with our medicines.
To help HCPs share new data on our products and understand their clinical use, in some cases we:
- Make fair market value payments to global expert practitioners who speak about the new science behind selected GSK products, their associated diseases and clinical practice in promotional settings
- Pay reasonable travel costs (except in the US) for an HCP to attend a GSK-organized standalone meeting to learn about data and clinical expertise.
- Directly pay registration fees for HCPs to attend remote congress webinars/webcasts. We do not sponsor HCPs to attend local and international conferences.
This policy is limited to select products in certain countries around the world and controls and training are in place, including measures to track appropriate payment and use of external speakers.
Where legally permitted, we will report individual-level payments made each year to HCPs for attending educational meetings and for the provision of services, such as speaking at events or attending advisory boards. Where individual level disclosure is not legally permitted, we will continue to report aggregate payments.
Collaborating on clinical trials and research
Healthcare professionals (HCPs) help us identify potential volunteers for clinical studies, administer the investigational medicine or vaccine to patients, and monitor the results.
All HCPs who work with us on clinical studies have contracts and are paid for their work on these clinical studies. This payment covers their time, plus the cost of investigations they may need to carry out regarding the suitability of a patient and the effectiveness of the treatment.
We have a commitment to publicly disclose the research payments that are made to healthcare professionals and to their institutions for conducting clinical research.
Disclosure of payments made to HCPs
We acknowledge the importance of increased transparency and of putting the patient at the centre of every decision we take. Since 2019, where legally permitted, we report individual level payments made each year to HCPs for attending educational meetings and for the provision of services, such as speaking at events or attending advisory boards. Where individual level disclosure is not legally permitted, we will continue to report aggregate payments. Find out more about our transparency reporting in Canada here.
